In the cancer cells, miR-124 might target ROR2-mediated Wnt signaling and B7-H3, a T cell co-stimulatory molecule, to produce its anti-tumor action, while it might target Synpo to produce its analgesic effect in the spinal cord. The gene discussed is ROR2; the disease is neoplasm.